FDA Inspection 1039881 — Kalpesh Patel
The FDA completed an inspection of Kalpesh Patel on Nov 17, 2017 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tucson, AZ (United States)
Additional Details
Clinical Investigator (CI)